nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—KIT—coronary artery disease	0.14	0.596	CbGaD
Imatinib—CYP2C19—coronary artery disease	0.0608	0.26	CbGaD
Imatinib—ALB—coronary artery disease	0.0337	0.144	CbGaD
Imatinib—CA14—Furosemide—coronary artery disease	0.0191	0.0421	CbGbCtD
Imatinib—CA6—Furosemide—coronary artery disease	0.0181	0.0399	CbGbCtD
Imatinib—ORM1—Penbutolol—coronary artery disease	0.0171	0.0377	CbGbCtD
Imatinib—CA7—Furosemide—coronary artery disease	0.0158	0.0348	CbGbCtD
Imatinib—ORM1—Pitavastatin—coronary artery disease	0.015	0.033	CbGbCtD
Imatinib—CA12—Furosemide—coronary artery disease	0.0135	0.0299	CbGbCtD
Imatinib—CA9—Furosemide—coronary artery disease	0.0135	0.0299	CbGbCtD
Imatinib—CA1—Furosemide—coronary artery disease	0.0127	0.0279	CbGbCtD
Imatinib—CA2—Furosemide—coronary artery disease	0.0109	0.0242	CbGbCtD
Imatinib—ABCG2—Telmisartan—coronary artery disease	0.00913	0.0201	CbGbCtD
Imatinib—ABCG2—Pitavastatin—coronary artery disease	0.00913	0.0201	CbGbCtD
Imatinib—CYP3A7—Eplerenone—coronary artery disease	0.00717	0.0158	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Eplerenone—coronary artery disease	0.00717	0.0158	CbGbCtD
Imatinib—ABCG2—Rosuvastatin—coronary artery disease	0.00673	0.0148	CbGbCtD
Imatinib—ABCG2—Ezetimibe—coronary artery disease	0.00673	0.0148	CbGbCtD
Imatinib—ALB—Pitavastatin—coronary artery disease	0.00629	0.0139	CbGbCtD
Imatinib—ABCG2—Pravastatin—coronary artery disease	0.00612	0.0135	CbGbCtD
Imatinib—ALB—Valsartan—coronary artery disease	0.00612	0.0135	CbGbCtD
Imatinib—ABCB1—Ticagrelor—coronary artery disease	0.00609	0.0134	CbGbCtD
Imatinib—PTGS1—Acetylsalicylic acid—coronary artery disease	0.00605	0.0134	CbGbCtD
Imatinib—CYP3A5—Clopidogrel—coronary artery disease	0.00578	0.0128	CbGbCtD
Imatinib—CYP2C9—Fenofibrate—coronary artery disease	0.0056	0.0123	CbGbCtD
Imatinib—CYP2C19—Gemfibrozil—coronary artery disease	0.00538	0.0119	CbGbCtD
Imatinib—CYP3A5—Eplerenone—coronary artery disease	0.00538	0.0119	CbGbCtD
Imatinib—CYP1A2—Gemfibrozil—coronary artery disease	0.00497	0.011	CbGbCtD
Imatinib—CYP2C19—Clopidogrel—coronary artery disease	0.00467	0.0103	CbGbCtD
Imatinib—ALB—Rosuvastatin—coronary artery disease	0.00464	0.0102	CbGbCtD
Imatinib—CYP3A7—Simvastatin—coronary artery disease	0.00462	0.0102	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Simvastatin—coronary artery disease	0.00462	0.0102	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Lovastatin—coronary artery disease	0.00452	0.00997	CbGbCtD
Imatinib—CYP3A7—Lovastatin—coronary artery disease	0.00452	0.00997	CbGbCtD
Imatinib—ALB—Acetylsalicylic acid—coronary artery disease	0.00452	0.00997	CbGbCtD
Imatinib—CYP2C9—Gemfibrozil—coronary artery disease	0.00447	0.00987	CbGbCtD
Imatinib—ALB—Captopril—coronary artery disease	0.00446	0.00985	CbGbCtD
Imatinib—CYP1A2—Clopidogrel—coronary artery disease	0.0043	0.0095	CbGbCtD
Imatinib—CYP3A7—Atorvastatin—coronary artery disease	0.00412	0.00908	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Atorvastatin—coronary artery disease	0.00412	0.00908	CbGbCtD
Imatinib—CYP2C19—Telmisartan—coronary artery disease	0.00408	0.009	CbGbCtD
Imatinib—CYP2C9—Clopidogrel—coronary artery disease	0.00388	0.00856	CbGbCtD
Imatinib—ABCB1—Perindopril—coronary artery disease	0.00376	0.00831	CbGbCtD
Imatinib—ABCB1—Clopidogrel—coronary artery disease	0.00376	0.00831	CbGbCtD
Imatinib—CYP3A5—Rosuvastatin—coronary artery disease	0.00373	0.00822	CbGbCtD
Imatinib—CYP3A4—Ticagrelor—coronary artery disease	0.00365	0.00805	CbGbCtD
Imatinib—ALB—Furosemide—coronary artery disease	0.00359	0.00791	CbGbCtD
Imatinib—ALB—Losartan—coronary artery disease	0.00351	0.00775	CbGbCtD
Imatinib—CYP3A5—Simvastatin—coronary artery disease	0.00347	0.00764	CbGbCtD
Imatinib—CYP3A5—Pravastatin—coronary artery disease	0.00339	0.00748	CbGbCtD
Imatinib—CYP3A5—Lovastatin—coronary artery disease	0.00339	0.00748	CbGbCtD
Imatinib—CYP2C9—Pitavastatin—coronary artery disease	0.00339	0.00748	CbGbCtD
Imatinib—CYP2C9—Valsartan—coronary artery disease	0.0033	0.00728	CbGbCtD
Imatinib—ABCB1—Pitavastatin—coronary artery disease	0.00329	0.00726	CbGbCtD
Imatinib—ABCB1—Telmisartan—coronary artery disease	0.00329	0.00726	CbGbCtD
Imatinib—CYP2C19—Timolol—coronary artery disease	0.00329	0.00725	CbGbCtD
Imatinib—CA3—pericardium—coronary artery disease	0.00326	0.0882	CbGeAlD
Imatinib—CYP3A4—Fenofibrate—coronary artery disease	0.00325	0.00718	CbGbCtD
Imatinib—ABCB1—Enalapril—coronary artery disease	0.00312	0.00688	CbGbCtD
Imatinib—ABCB1—Lisinopril—coronary artery disease	0.00312	0.00688	CbGbCtD
Imatinib—CYP3A5—Atorvastatin—coronary artery disease	0.00309	0.00681	CbGbCtD
Imatinib—CYP2C19—Rosuvastatin—coronary artery disease	0.00301	0.00663	CbGbCtD
Imatinib—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00293	0.00646	CbGbCtD
Imatinib—CYP3A5—Losartan—coronary artery disease	0.00282	0.00623	CbGbCtD
Imatinib—CYP2C9—cardial valve—coronary artery disease	0.00281	0.0759	CbGeAlD
Imatinib—CYP2C19—Simvastatin—coronary artery disease	0.00279	0.00617	CbGbCtD
Imatinib—CYP2C19—Lovastatin—coronary artery disease	0.00274	0.00603	CbGbCtD
Imatinib—CYP2D6—Niacin—coronary artery disease	0.00269	0.00593	CbGbCtD
Imatinib—ABCB1—Timolol—coronary artery disease	0.00265	0.00585	CbGbCtD
Imatinib—CYP3A4—Gemfibrozil—coronary artery disease	0.0026	0.00574	CbGbCtD
Imatinib—CYP2C9—Rosuvastatin—coronary artery disease	0.0025	0.00551	CbGbCtD
Imatinib—CYP2D6—Timolol—coronary artery disease	0.0025	0.00551	CbGbCtD
Imatinib—CYP2C19—Atorvastatin—coronary artery disease	0.00249	0.0055	CbGbCtD
Imatinib—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00244	0.00537	CbGbCtD
Imatinib—ABCB1—Ezetimibe—coronary artery disease	0.00243	0.00535	CbGbCtD
Imatinib—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00236	0.00522	CbGbCtD
Imatinib—ABCB1—Captopril—coronary artery disease	0.00234	0.00515	CbGbCtD
Imatinib—CYP2C9—Simvastatin—coronary artery disease	0.00232	0.00513	CbGbCtD
Imatinib—CYP2C19—Losartan—coronary artery disease	0.00228	0.00503	CbGbCtD
Imatinib—CYP2C9—Lovastatin—coronary artery disease	0.00227	0.00502	CbGbCtD
Imatinib—CYP2C9—Pravastatin—coronary artery disease	0.00227	0.00502	CbGbCtD
Imatinib—CYP3A4—Clopidogrel—coronary artery disease	0.00226	0.00498	CbGbCtD
Imatinib—ABCB1—Simvastatin—coronary artery disease	0.00226	0.00498	CbGbCtD
Imatinib—ABCB1—Lovastatin—coronary artery disease	0.00221	0.00487	CbGbCtD
Imatinib—ABCB1—Pravastatin—coronary artery disease	0.00221	0.00487	CbGbCtD
Imatinib—CYP2D6—Captopril—coronary artery disease	0.0022	0.00485	CbGbCtD
Imatinib—CYP2D6—Simvastatin—coronary artery disease	0.00212	0.00469	CbGbCtD
Imatinib—CYP1A2—Losartan—coronary artery disease	0.0021	0.00464	CbGbCtD
Imatinib—CYP3A4—Eplerenone—coronary artery disease	0.0021	0.00463	CbGbCtD
Imatinib—CYP2D6—Pravastatin—coronary artery disease	0.00208	0.00459	CbGbCtD
Imatinib—CYP2D6—Lovastatin—coronary artery disease	0.00208	0.00459	CbGbCtD
Imatinib—CYP2C9—Atorvastatin—coronary artery disease	0.00207	0.00457	CbGbCtD
Imatinib—ABCB1—Atorvastatin—coronary artery disease	0.00201	0.00443	CbGbCtD
Imatinib—CYP2C9—Losartan—coronary artery disease	0.00189	0.00418	CbGbCtD
Imatinib—CYP2D6—Atorvastatin—coronary artery disease	0.00189	0.00418	CbGbCtD
Imatinib—CYP3A4—Enalapril—coronary artery disease	0.00187	0.00412	CbGbCtD
Imatinib—ABCB1—Losartan—coronary artery disease	0.00184	0.00406	CbGbCtD
Imatinib—CYP3A4—Ezetimibe—coronary artery disease	0.00145	0.00321	CbGbCtD
Imatinib—CYP3A4—Rosuvastatin—coronary artery disease	0.00145	0.00321	CbGbCtD
Imatinib—CYP3A4—Simvastatin—coronary artery disease	0.00135	0.00298	CbGbCtD
Imatinib—CYP3A4—Lovastatin—coronary artery disease	0.00132	0.00292	CbGbCtD
Imatinib—CYP3A4—Pravastatin—coronary artery disease	0.00132	0.00292	CbGbCtD
Imatinib—DDR1—cardiac ventricle—coronary artery disease	0.0013	0.0352	CbGeAlD
Imatinib—DDR1—myocardium—coronary artery disease	0.00123	0.0331	CbGeAlD
Imatinib—CYP3A4—Atorvastatin—coronary artery disease	0.0012	0.00266	CbGbCtD
Imatinib—CYP3A4—Losartan—coronary artery disease	0.0011	0.00243	CbGbCtD
Imatinib—ABCA3—heart—coronary artery disease	0.000927	0.0251	CbGeAlD
Imatinib—Ponatinib—TEK—coronary artery disease	0.000876	0.261	CrCbGaD
Imatinib—DDR1—heart—coronary artery disease	0.000855	0.0231	CbGeAlD
Imatinib—CA3—cardiac ventricle—coronary artery disease	0.000768	0.0208	CbGeAlD
Imatinib—PIP4K2C—myocardium—coronary artery disease	0.000756	0.0205	CbGeAlD
Imatinib—DDR1—cardiac atrium—coronary artery disease	0.000731	0.0198	CbGeAlD
Imatinib—CA3—myocardium—coronary artery disease	0.000722	0.0195	CbGeAlD
Imatinib—KIT—endothelium—coronary artery disease	0.000709	0.0192	CbGeAlD
Imatinib—Nilotinib—MAPK14—coronary artery disease	0.000707	0.21	CrCbGaD
Imatinib—CA14—cardiac ventricle—coronary artery disease	0.000697	0.0189	CbGeAlD
Imatinib—ABCA3—blood—coronary artery disease	0.000691	0.0187	CbGeAlD
Imatinib—Nilotinib—TEK—coronary artery disease	0.000647	0.192	CrCbGaD
Imatinib—DDR1—blood—coronary artery disease	0.000638	0.0173	CbGeAlD
Imatinib—NQO2—cardiac ventricle—coronary artery disease	0.00059	0.016	CbGeAlD
Imatinib—ABL2—heart—coronary artery disease	0.000558	0.0151	CbGeAlD
Imatinib—NQO2—myocardium—coronary artery disease	0.000555	0.015	CbGeAlD
Imatinib—PIP4K2C—heart—coronary artery disease	0.000528	0.0143	CbGeAlD
Imatinib—CA3—heart—coronary artery disease	0.000504	0.0136	CbGeAlD
Imatinib—CA3—cardiovascular system—coronary artery disease	0.000476	0.0129	CbGeAlD
Imatinib—LCK—heart—coronary artery disease	0.000469	0.0127	CbGeAlD
Imatinib—PDGFRB—cardiac ventricle—coronary artery disease	0.00046	0.0124	CbGeAlD
Imatinib—CA14—heart—coronary artery disease	0.000458	0.0124	CbGeAlD
Imatinib—PIP4K2C—cardiac atrium—coronary artery disease	0.000451	0.0122	CbGeAlD
Imatinib—KIT—myocardium—coronary artery disease	0.000443	0.012	CbGeAlD
Imatinib—PDGFRB—myocardium—coronary artery disease	0.000433	0.0117	CbGeAlD
Imatinib—CA3—cardiac atrium—coronary artery disease	0.000431	0.0117	CbGeAlD
Imatinib—Ponatinib—KDR—coronary artery disease	0.000428	0.127	CrCbGaD
Imatinib—ABL2—blood—coronary artery disease	0.000416	0.0113	CbGeAlD
Imatinib—ABL1—cardiac ventricle—coronary artery disease	0.00041	0.0111	CbGeAlD
Imatinib—Ponatinib—KIT—coronary artery disease	0.000404	0.12	CrCbGaD
Imatinib—PIP4K2C—blood—coronary artery disease	0.000394	0.0107	CbGeAlD
Imatinib—CA14—cardiac atrium—coronary artery disease	0.000391	0.0106	CbGeAlD
Imatinib—NQO2—heart—coronary artery disease	0.000388	0.0105	CbGeAlD
Imatinib—PDGFRA—heart—coronary artery disease	0.000387	0.0105	CbGeAlD
Imatinib—ABL1—myocardium—coronary artery disease	0.000386	0.0104	CbGeAlD
Imatinib—PTGS1—artery—coronary artery disease	0.000384	0.0104	CbGeAlD
Imatinib—PDGFRA—cardiovascular system—coronary artery disease	0.000365	0.00987	CbGeAlD
Imatinib—LCK—blood—coronary artery disease	0.00035	0.00946	CbGeAlD
Imatinib—CSF1R—heart—coronary artery disease	0.00034	0.00921	CbGeAlD
Imatinib—NQO2—cardiac atrium—coronary artery disease	0.000332	0.00897	CbGeAlD
Imatinib—PTGS1—endothelium—coronary artery disease	0.000325	0.00878	CbGeAlD
Imatinib—CSF1R—cardiovascular system—coronary artery disease	0.000321	0.00869	CbGeAlD
Imatinib—SLC47A1—heart—coronary artery disease	0.000311	0.00841	CbGeAlD
Imatinib—KIT—heart—coronary artery disease	0.000309	0.00836	CbGeAlD
Imatinib—PDGFRB—heart—coronary artery disease	0.000302	0.00817	CbGeAlD
Imatinib—Nilotinib—KIT—coronary artery disease	0.000298	0.0887	CrCbGaD
Imatinib—KIT—cardiovascular system—coronary artery disease	0.000292	0.00789	CbGeAlD
Imatinib—CSF1R—cardiac atrium—coronary artery disease	0.000291	0.00788	CbGeAlD
Imatinib—NQO2—blood—coronary artery disease	0.000289	0.00783	CbGeAlD
Imatinib—PDGFRA—blood—coronary artery disease	0.000289	0.00781	CbGeAlD
Imatinib—PDGFRB—cardiovascular system—coronary artery disease	0.000285	0.00771	CbGeAlD
Imatinib—CA1—heart—coronary artery disease	0.000283	0.00765	CbGeAlD
Imatinib—CA2—cardiac ventricle—coronary artery disease	0.000279	0.00755	CbGeAlD
Imatinib—ABL1—heart—coronary artery disease	0.000269	0.00728	CbGeAlD
Imatinib—CA1—cardiovascular system—coronary artery disease	0.000267	0.00722	CbGeAlD
Imatinib—CA2—myocardium—coronary artery disease	0.000263	0.0071	CbGeAlD
Imatinib—PDGFRB—cardiac atrium—coronary artery disease	0.000258	0.00699	CbGeAlD
Imatinib—CSF1R—blood—coronary artery disease	0.000254	0.00687	CbGeAlD
Imatinib—ABL1—cardiovascular system—coronary artery disease	0.000254	0.00687	CbGeAlD
Imatinib—ALB—heart—coronary artery disease	0.000248	0.00672	CbGeAlD
Imatinib—SLC47A1—blood—coronary artery disease	0.000232	0.00628	CbGeAlD
Imatinib—KIT—blood—coronary artery disease	0.000231	0.00624	CbGeAlD
Imatinib—ABL1—cardiac atrium—coronary artery disease	0.00023	0.00623	CbGeAlD
Imatinib—PDGFRB—blood—coronary artery disease	0.000225	0.0061	CbGeAlD
Imatinib—ORM1—blood—coronary artery disease	0.000211	0.00572	CbGeAlD
Imatinib—CA1—blood—coronary artery disease	0.000211	0.00571	CbGeAlD
Imatinib—PTGS1—myocardium—coronary artery disease	0.000203	0.00549	CbGeAlD
Imatinib—ABL1—blood—coronary artery disease	0.000201	0.00543	CbGeAlD
Imatinib—SLC22A1—blood—coronary artery disease	0.000194	0.00524	CbGeAlD
Imatinib—CA2—heart—coronary artery disease	0.000183	0.00496	CbGeAlD
Imatinib—CA2—cardiovascular system—coronary artery disease	0.000173	0.00468	CbGeAlD
Imatinib—ABCG2—heart—coronary artery disease	0.00017	0.00459	CbGeAlD
Imatinib—CA2—cardiac atrium—coronary artery disease	0.000157	0.00424	CbGeAlD
Imatinib—CYP2C9—heart—coronary artery disease	0.000155	0.00419	CbGeAlD
Imatinib—CYP2C19—blood—coronary artery disease	0.000149	0.00404	CbGeAlD
Imatinib—CYP2C9—cardiovascular system—coronary artery disease	0.000146	0.00396	CbGeAlD
Imatinib—PTGS1—heart—coronary artery disease	0.000142	0.00383	CbGeAlD
Imatinib—CA2—blood—coronary artery disease	0.000137	0.0037	CbGeAlD
Imatinib—PTGS1—cardiovascular system—coronary artery disease	0.000134	0.00361	CbGeAlD
Imatinib—ABCG2—blood—coronary artery disease	0.000127	0.00343	CbGeAlD
Imatinib—CYP1A2—blood—coronary artery disease	0.000122	0.0033	CbGeAlD
Imatinib—PTGS1—cardiac atrium—coronary artery disease	0.000121	0.00327	CbGeAlD
Imatinib—CYP3A5—blood—coronary artery disease	0.000118	0.00318	CbGeAlD
Imatinib—CYP2C9—blood—coronary artery disease	0.000116	0.00313	CbGeAlD
Imatinib—PTGS1—blood—coronary artery disease	0.000106	0.00286	CbGeAlD
Imatinib—CYP3A4—blood—coronary artery disease	8.82e-05	0.00239	CbGeAlD
Imatinib—CYP2D6—blood—coronary artery disease	8.68e-05	0.00235	CbGeAlD
Imatinib—ABCB1—heart—coronary artery disease	8.37e-05	0.00226	CbGeAlD
Imatinib—ABCB1—cardiovascular system—coronary artery disease	7.9e-05	0.00214	CbGeAlD
Imatinib—ABCB1—blood—coronary artery disease	6.24e-05	0.00169	CbGeAlD
Imatinib—Malaise—Lisinopril—coronary artery disease	2.46e-05	0.000154	CcSEcCtD
Imatinib—Anaphylactic shock—Ramipril—coronary artery disease	2.46e-05	0.000154	CcSEcCtD
Imatinib—Oedema—Ramipril—coronary artery disease	2.46e-05	0.000154	CcSEcCtD
Imatinib—Vertigo—Lisinopril—coronary artery disease	2.45e-05	0.000154	CcSEcCtD
Imatinib—Dry mouth—Timolol—coronary artery disease	2.45e-05	0.000154	CcSEcCtD
Imatinib—Pain—Losartan—coronary artery disease	2.45e-05	0.000154	CcSEcCtD
Imatinib—Constipation—Losartan—coronary artery disease	2.45e-05	0.000154	CcSEcCtD
Imatinib—Syncope—Lisinopril—coronary artery disease	2.45e-05	0.000153	CcSEcCtD
Imatinib—Vomiting—Eplerenone—coronary artery disease	2.45e-05	0.000153	CcSEcCtD
Imatinib—Feeling abnormal—Furosemide—coronary artery disease	2.45e-05	0.000153	CcSEcCtD
Imatinib—Leukopenia—Lisinopril—coronary artery disease	2.45e-05	0.000153	CcSEcCtD
Imatinib—Nausea—Fenofibrate—coronary artery disease	2.44e-05	0.000153	CcSEcCtD
Imatinib—Pruritus—Niacin—coronary artery disease	2.44e-05	0.000153	CcSEcCtD
Imatinib—Asthenia—Pravastatin—coronary artery disease	2.44e-05	0.000153	CcSEcCtD
Imatinib—Gastrointestinal pain—Furosemide—coronary artery disease	2.43e-05	0.000152	CcSEcCtD
Imatinib—Rash—Eplerenone—coronary artery disease	2.43e-05	0.000152	CcSEcCtD
Imatinib—Urticaria—Perindopril—coronary artery disease	2.43e-05	0.000152	CcSEcCtD
Imatinib—Hypersensitivity—Trandolapril—coronary artery disease	2.43e-05	0.000152	CcSEcCtD
Imatinib—Dermatitis—Eplerenone—coronary artery disease	2.43e-05	0.000152	CcSEcCtD
Imatinib—Diarrhoea—Valsartan—coronary artery disease	2.43e-05	0.000152	CcSEcCtD
Imatinib—Confusional state—Timolol—coronary artery disease	2.42e-05	0.000152	CcSEcCtD
Imatinib—Shock—Ramipril—coronary artery disease	2.42e-05	0.000152	CcSEcCtD
Imatinib—Hypersensitivity—Enalapril—coronary artery disease	2.42e-05	0.000152	CcSEcCtD
Imatinib—Body temperature increased—Perindopril—coronary artery disease	2.42e-05	0.000151	CcSEcCtD
Imatinib—Abdominal pain—Perindopril—coronary artery disease	2.42e-05	0.000151	CcSEcCtD
Imatinib—Palpitations—Lisinopril—coronary artery disease	2.41e-05	0.000151	CcSEcCtD
Imatinib—Diarrhoea—Olmesartan—coronary artery disease	2.41e-05	0.000151	CcSEcCtD
Imatinib—Headache—Eplerenone—coronary artery disease	2.41e-05	0.000151	CcSEcCtD
Imatinib—Nervous system disorder—Ramipril—coronary artery disease	2.41e-05	0.000151	CcSEcCtD
Imatinib—Thrombocytopenia—Ramipril—coronary artery disease	2.41e-05	0.000151	CcSEcCtD
Imatinib—Oedema—Timolol—coronary artery disease	2.4e-05	0.000151	CcSEcCtD
Imatinib—Anaphylactic shock—Timolol—coronary artery disease	2.4e-05	0.000151	CcSEcCtD
Imatinib—Pruritus—Pravastatin—coronary artery disease	2.4e-05	0.00015	CcSEcCtD
Imatinib—Loss of consciousness—Lisinopril—coronary artery disease	2.4e-05	0.00015	CcSEcCtD
Imatinib—Nausea—Clopidogrel—coronary artery disease	2.4e-05	0.00015	CcSEcCtD
Imatinib—Tachycardia—Ramipril—coronary artery disease	2.4e-05	0.00015	CcSEcCtD
Imatinib—Skin disorder—Ramipril—coronary artery disease	2.39e-05	0.00015	CcSEcCtD
Imatinib—Infection—Timolol—coronary artery disease	2.39e-05	0.00015	CcSEcCtD
Imatinib—Vomiting—Simvastatin—coronary artery disease	2.39e-05	0.00015	CcSEcCtD
Imatinib—Hypersensitivity—Telmisartan—coronary artery disease	2.39e-05	0.000149	CcSEcCtD
Imatinib—Cough—Lisinopril—coronary artery disease	2.38e-05	0.000149	CcSEcCtD
Imatinib—Nausea—Lovastatin—coronary artery disease	2.38e-05	0.000149	CcSEcCtD
Imatinib—Hyperhidrosis—Ramipril—coronary artery disease	2.38e-05	0.000149	CcSEcCtD
Imatinib—Rash—Simvastatin—coronary artery disease	2.37e-05	0.000148	CcSEcCtD
Imatinib—Dermatitis—Simvastatin—coronary artery disease	2.37e-05	0.000148	CcSEcCtD
Imatinib—Asthenia—Trandolapril—coronary artery disease	2.37e-05	0.000148	CcSEcCtD
Imatinib—Shock—Timolol—coronary artery disease	2.36e-05	0.000148	CcSEcCtD
Imatinib—Feeling abnormal—Losartan—coronary artery disease	2.36e-05	0.000148	CcSEcCtD
Imatinib—Urticaria—Furosemide—coronary artery disease	2.36e-05	0.000148	CcSEcCtD
Imatinib—Diarrhoea—Niacin—coronary artery disease	2.36e-05	0.000148	CcSEcCtD
Imatinib—Nervous system disorder—Timolol—coronary artery disease	2.36e-05	0.000148	CcSEcCtD
Imatinib—Asthenia—Enalapril—coronary artery disease	2.36e-05	0.000148	CcSEcCtD
Imatinib—Headache—Simvastatin—coronary artery disease	2.35e-05	0.000147	CcSEcCtD
Imatinib—Abdominal pain—Furosemide—coronary artery disease	2.35e-05	0.000147	CcSEcCtD
Imatinib—Body temperature increased—Furosemide—coronary artery disease	2.35e-05	0.000147	CcSEcCtD
Imatinib—Gastrointestinal pain—Losartan—coronary artery disease	2.34e-05	0.000147	CcSEcCtD
Imatinib—Dizziness—Valsartan—coronary artery disease	2.34e-05	0.000147	CcSEcCtD
Imatinib—Anorexia—Ramipril—coronary artery disease	2.34e-05	0.000147	CcSEcCtD
Imatinib—Nausea—Ezetimibe—coronary artery disease	2.34e-05	0.000146	CcSEcCtD
Imatinib—Skin disorder—Timolol—coronary artery disease	2.33e-05	0.000146	CcSEcCtD
Imatinib—Dizziness—Olmesartan—coronary artery disease	2.33e-05	0.000146	CcSEcCtD
Imatinib—Pruritus—Trandolapril—coronary artery disease	2.33e-05	0.000146	CcSEcCtD
Imatinib—Arthralgia—Lisinopril—coronary artery disease	2.33e-05	0.000146	CcSEcCtD
Imatinib—Chest pain—Lisinopril—coronary artery disease	2.33e-05	0.000146	CcSEcCtD
Imatinib—Myalgia—Lisinopril—coronary artery disease	2.33e-05	0.000146	CcSEcCtD
Imatinib—Hyperhidrosis—Timolol—coronary artery disease	2.32e-05	0.000146	CcSEcCtD
Imatinib—Asthenia—Telmisartan—coronary artery disease	2.32e-05	0.000146	CcSEcCtD
Imatinib—Pruritus—Enalapril—coronary artery disease	2.32e-05	0.000145	CcSEcCtD
Imatinib—Diarrhoea—Pravastatin—coronary artery disease	2.32e-05	0.000145	CcSEcCtD
Imatinib—Anxiety—Lisinopril—coronary artery disease	2.32e-05	0.000145	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	2.31e-05	0.000145	CcSEcCtD
Imatinib—Discomfort—Lisinopril—coronary artery disease	2.3e-05	0.000144	CcSEcCtD
Imatinib—Hypotension—Ramipril—coronary artery disease	2.3e-05	0.000144	CcSEcCtD
Imatinib—Anorexia—Timolol—coronary artery disease	2.29e-05	0.000144	CcSEcCtD
Imatinib—Pruritus—Telmisartan—coronary artery disease	2.29e-05	0.000144	CcSEcCtD
Imatinib—Nausea—Eplerenone—coronary artery disease	2.29e-05	0.000143	CcSEcCtD
Imatinib—Dizziness—Niacin—coronary artery disease	2.28e-05	0.000143	CcSEcCtD
Imatinib—Urticaria—Losartan—coronary artery disease	2.28e-05	0.000143	CcSEcCtD
Imatinib—Dry mouth—Lisinopril—coronary artery disease	2.28e-05	0.000143	CcSEcCtD
Imatinib—Body temperature increased—Losartan—coronary artery disease	2.27e-05	0.000142	CcSEcCtD
Imatinib—Abdominal pain—Losartan—coronary artery disease	2.27e-05	0.000142	CcSEcCtD
Imatinib—Asthenia—Captopril—coronary artery disease	2.26e-05	0.000142	CcSEcCtD
Imatinib—Diarrhoea—Trandolapril—coronary artery disease	2.26e-05	0.000141	CcSEcCtD
Imatinib—Vomiting—Valsartan—coronary artery disease	2.25e-05	0.000141	CcSEcCtD
Imatinib—Confusional state—Lisinopril—coronary artery disease	2.25e-05	0.000141	CcSEcCtD
Imatinib—Diarrhoea—Enalapril—coronary artery disease	2.25e-05	0.000141	CcSEcCtD
Imatinib—Hypotension—Timolol—coronary artery disease	2.25e-05	0.000141	CcSEcCtD
Imatinib—Dizziness—Pravastatin—coronary artery disease	2.24e-05	0.000141	CcSEcCtD
Imatinib—Vomiting—Olmesartan—coronary artery disease	2.24e-05	0.000141	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Ramipril—coronary artery disease	2.24e-05	0.00014	CcSEcCtD
Imatinib—Rash—Valsartan—coronary artery disease	2.24e-05	0.00014	CcSEcCtD
Imatinib—Dermatitis—Valsartan—coronary artery disease	2.23e-05	0.00014	CcSEcCtD
Imatinib—Nausea—Simvastatin—coronary artery disease	2.23e-05	0.00014	CcSEcCtD
Imatinib—Oedema—Lisinopril—coronary artery disease	2.23e-05	0.00014	CcSEcCtD
Imatinib—Anaphylactic shock—Lisinopril—coronary artery disease	2.23e-05	0.00014	CcSEcCtD
Imatinib—Pruritus—Captopril—coronary artery disease	2.23e-05	0.00014	CcSEcCtD
Imatinib—Rash—Olmesartan—coronary artery disease	2.22e-05	0.000139	CcSEcCtD
Imatinib—Insomnia—Ramipril—coronary artery disease	2.22e-05	0.000139	CcSEcCtD
Imatinib—Dermatitis—Olmesartan—coronary artery disease	2.22e-05	0.000139	CcSEcCtD
Imatinib—Headache—Valsartan—coronary artery disease	2.22e-05	0.000139	CcSEcCtD
Imatinib—Diarrhoea—Telmisartan—coronary artery disease	2.22e-05	0.000139	CcSEcCtD
Imatinib—Infection—Lisinopril—coronary artery disease	2.22e-05	0.000139	CcSEcCtD
Imatinib—Headache—Olmesartan—coronary artery disease	2.21e-05	0.000138	CcSEcCtD
Imatinib—Paraesthesia—Ramipril—coronary artery disease	2.21e-05	0.000138	CcSEcCtD
Imatinib—Shock—Lisinopril—coronary artery disease	2.19e-05	0.000137	CcSEcCtD
Imatinib—Asthenia—Perindopril—coronary artery disease	2.19e-05	0.000137	CcSEcCtD
Imatinib—Dyspnoea—Ramipril—coronary artery disease	2.19e-05	0.000137	CcSEcCtD
Imatinib—Vomiting—Niacin—coronary artery disease	2.19e-05	0.000137	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Timolol—coronary artery disease	2.19e-05	0.000137	CcSEcCtD
Imatinib—Hypersensitivity—Furosemide—coronary artery disease	2.19e-05	0.000137	CcSEcCtD
Imatinib—Somnolence—Ramipril—coronary artery disease	2.19e-05	0.000137	CcSEcCtD
Imatinib—Thrombocytopenia—Lisinopril—coronary artery disease	2.18e-05	0.000137	CcSEcCtD
Imatinib—Dizziness—Trandolapril—coronary artery disease	2.18e-05	0.000137	CcSEcCtD
Imatinib—Tachycardia—Lisinopril—coronary artery disease	2.18e-05	0.000136	CcSEcCtD
Imatinib—Insomnia—Timolol—coronary artery disease	2.17e-05	0.000136	CcSEcCtD
Imatinib—Rash—Niacin—coronary artery disease	2.17e-05	0.000136	CcSEcCtD
Imatinib—Dermatitis—Niacin—coronary artery disease	2.17e-05	0.000136	CcSEcCtD
Imatinib—Dizziness—Enalapril—coronary artery disease	2.17e-05	0.000136	CcSEcCtD
Imatinib—Skin disorder—Lisinopril—coronary artery disease	2.17e-05	0.000136	CcSEcCtD
Imatinib—Dyspepsia—Ramipril—coronary artery disease	2.16e-05	0.000136	CcSEcCtD
Imatinib—Pruritus—Perindopril—coronary artery disease	2.16e-05	0.000135	CcSEcCtD
Imatinib—Headache—Niacin—coronary artery disease	2.16e-05	0.000135	CcSEcCtD
Imatinib—Paraesthesia—Timolol—coronary artery disease	2.16e-05	0.000135	CcSEcCtD
Imatinib—Vomiting—Pravastatin—coronary artery disease	2.16e-05	0.000135	CcSEcCtD
Imatinib—Hyperhidrosis—Lisinopril—coronary artery disease	2.16e-05	0.000135	CcSEcCtD
Imatinib—Diarrhoea—Captopril—coronary artery disease	2.15e-05	0.000135	CcSEcCtD
Imatinib—Dyspnoea—Timolol—coronary artery disease	2.14e-05	0.000134	CcSEcCtD
Imatinib—Dizziness—Telmisartan—coronary artery disease	2.14e-05	0.000134	CcSEcCtD
Imatinib—Rash—Pravastatin—coronary artery disease	2.14e-05	0.000134	CcSEcCtD
Imatinib—Dermatitis—Pravastatin—coronary artery disease	2.14e-05	0.000134	CcSEcCtD
Imatinib—Decreased appetite—Ramipril—coronary artery disease	2.14e-05	0.000134	CcSEcCtD
Imatinib—Somnolence—Timolol—coronary artery disease	2.14e-05	0.000134	CcSEcCtD
Imatinib—Asthenia—Furosemide—coronary artery disease	2.13e-05	0.000134	CcSEcCtD
Imatinib—Headache—Pravastatin—coronary artery disease	2.13e-05	0.000133	CcSEcCtD
Imatinib—Anorexia—Lisinopril—coronary artery disease	2.13e-05	0.000133	CcSEcCtD
Imatinib—Gastrointestinal disorder—Ramipril—coronary artery disease	2.12e-05	0.000133	CcSEcCtD
Imatinib—Fatigue—Ramipril—coronary artery disease	2.12e-05	0.000133	CcSEcCtD
Imatinib—Dyspepsia—Timolol—coronary artery disease	2.12e-05	0.000133	CcSEcCtD
Imatinib—Hypersensitivity—Losartan—coronary artery disease	2.11e-05	0.000132	CcSEcCtD
Imatinib—Nausea—Valsartan—coronary artery disease	2.11e-05	0.000132	CcSEcCtD
Imatinib—Pruritus—Furosemide—coronary artery disease	2.1e-05	0.000132	CcSEcCtD
Imatinib—Constipation—Ramipril—coronary artery disease	2.1e-05	0.000132	CcSEcCtD
Imatinib—Nausea—Olmesartan—coronary artery disease	2.1e-05	0.000131	CcSEcCtD
Imatinib—Vomiting—Trandolapril—coronary artery disease	2.1e-05	0.000131	CcSEcCtD
Imatinib—Diarrhoea—Perindopril—coronary artery disease	2.09e-05	0.000131	CcSEcCtD
Imatinib—Decreased appetite—Timolol—coronary artery disease	2.09e-05	0.000131	CcSEcCtD
Imatinib—Vomiting—Enalapril—coronary artery disease	2.09e-05	0.000131	CcSEcCtD
Imatinib—Hypotension—Lisinopril—coronary artery disease	2.08e-05	0.000131	CcSEcCtD
Imatinib—Dizziness—Captopril—coronary artery disease	2.08e-05	0.00013	CcSEcCtD
Imatinib—Rash—Trandolapril—coronary artery disease	2.08e-05	0.00013	CcSEcCtD
Imatinib—Dermatitis—Trandolapril—coronary artery disease	2.08e-05	0.00013	CcSEcCtD
Imatinib—Gastrointestinal disorder—Timolol—coronary artery disease	2.08e-05	0.00013	CcSEcCtD
Imatinib—Fatigue—Timolol—coronary artery disease	2.07e-05	0.00013	CcSEcCtD
Imatinib—Rash—Enalapril—coronary artery disease	2.07e-05	0.00013	CcSEcCtD
Imatinib—Dermatitis—Enalapril—coronary artery disease	2.07e-05	0.00013	CcSEcCtD
Imatinib—Headache—Trandolapril—coronary artery disease	2.07e-05	0.000129	CcSEcCtD
Imatinib—Vomiting—Telmisartan—coronary artery disease	2.06e-05	0.000129	CcSEcCtD
Imatinib—Asthenia—Losartan—coronary artery disease	2.06e-05	0.000129	CcSEcCtD
Imatinib—Headache—Enalapril—coronary artery disease	2.06e-05	0.000129	CcSEcCtD
Imatinib—Pain—Timolol—coronary artery disease	2.06e-05	0.000129	CcSEcCtD
Imatinib—Nausea—Niacin—coronary artery disease	2.05e-05	0.000128	CcSEcCtD
Imatinib—Rash—Telmisartan—coronary artery disease	2.04e-05	0.000128	CcSEcCtD
Imatinib—Dermatitis—Telmisartan—coronary artery disease	2.04e-05	0.000128	CcSEcCtD
Imatinib—Diarrhoea—Furosemide—coronary artery disease	2.03e-05	0.000127	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Lisinopril—coronary artery disease	2.03e-05	0.000127	CcSEcCtD
Imatinib—Pruritus—Losartan—coronary artery disease	2.03e-05	0.000127	CcSEcCtD
Imatinib—Headache—Telmisartan—coronary artery disease	2.03e-05	0.000127	CcSEcCtD
Imatinib—Feeling abnormal—Ramipril—coronary artery disease	2.03e-05	0.000127	CcSEcCtD
Imatinib—Dizziness—Perindopril—coronary artery disease	2.02e-05	0.000127	CcSEcCtD
Imatinib—Insomnia—Lisinopril—coronary artery disease	2.02e-05	0.000126	CcSEcCtD
Imatinib—Nausea—Pravastatin—coronary artery disease	2.02e-05	0.000126	CcSEcCtD
Imatinib—Gastrointestinal pain—Ramipril—coronary artery disease	2.01e-05	0.000126	CcSEcCtD
Imatinib—Paraesthesia—Lisinopril—coronary artery disease	2e-05	0.000125	CcSEcCtD
Imatinib—Vomiting—Captopril—coronary artery disease	2e-05	0.000125	CcSEcCtD
Imatinib—Dyspnoea—Lisinopril—coronary artery disease	1.99e-05	0.000125	CcSEcCtD
Imatinib—Rash—Captopril—coronary artery disease	1.99e-05	0.000124	CcSEcCtD
Imatinib—Dermatitis—Captopril—coronary artery disease	1.98e-05	0.000124	CcSEcCtD
Imatinib—Somnolence—Lisinopril—coronary artery disease	1.98e-05	0.000124	CcSEcCtD
Imatinib—Feeling abnormal—Timolol—coronary artery disease	1.98e-05	0.000124	CcSEcCtD
Imatinib—Headache—Captopril—coronary artery disease	1.97e-05	0.000124	CcSEcCtD
Imatinib—Gastrointestinal pain—Timolol—coronary artery disease	1.97e-05	0.000123	CcSEcCtD
Imatinib—Dizziness—Furosemide—coronary artery disease	1.97e-05	0.000123	CcSEcCtD
Imatinib—Dyspepsia—Lisinopril—coronary artery disease	1.96e-05	0.000123	CcSEcCtD
Imatinib—Diarrhoea—Losartan—coronary artery disease	1.96e-05	0.000123	CcSEcCtD
Imatinib—Nausea—Trandolapril—coronary artery disease	1.96e-05	0.000123	CcSEcCtD
Imatinib—Urticaria—Ramipril—coronary artery disease	1.95e-05	0.000122	CcSEcCtD
Imatinib—Nausea—Enalapril—coronary artery disease	1.95e-05	0.000122	CcSEcCtD
Imatinib—Vomiting—Perindopril—coronary artery disease	1.94e-05	0.000122	CcSEcCtD
Imatinib—Body temperature increased—Ramipril—coronary artery disease	1.94e-05	0.000122	CcSEcCtD
Imatinib—Abdominal pain—Ramipril—coronary artery disease	1.94e-05	0.000122	CcSEcCtD
Imatinib—Decreased appetite—Lisinopril—coronary artery disease	1.94e-05	0.000121	CcSEcCtD
Imatinib—Rash—Perindopril—coronary artery disease	1.93e-05	0.000121	CcSEcCtD
Imatinib—Dermatitis—Perindopril—coronary artery disease	1.93e-05	0.000121	CcSEcCtD
Imatinib—Gastrointestinal disorder—Lisinopril—coronary artery disease	1.93e-05	0.000121	CcSEcCtD
Imatinib—Nausea—Telmisartan—coronary artery disease	1.92e-05	0.00012	CcSEcCtD
Imatinib—Fatigue—Lisinopril—coronary artery disease	1.92e-05	0.00012	CcSEcCtD
Imatinib—Headache—Perindopril—coronary artery disease	1.92e-05	0.00012	CcSEcCtD
Imatinib—Urticaria—Timolol—coronary artery disease	1.91e-05	0.00012	CcSEcCtD
Imatinib—Pain—Lisinopril—coronary artery disease	1.91e-05	0.000119	CcSEcCtD
Imatinib—Constipation—Lisinopril—coronary artery disease	1.91e-05	0.000119	CcSEcCtD
Imatinib—Abdominal pain—Timolol—coronary artery disease	1.9e-05	0.000119	CcSEcCtD
Imatinib—Body temperature increased—Timolol—coronary artery disease	1.9e-05	0.000119	CcSEcCtD
Imatinib—Dizziness—Losartan—coronary artery disease	1.9e-05	0.000119	CcSEcCtD
Imatinib—Vomiting—Furosemide—coronary artery disease	1.89e-05	0.000118	CcSEcCtD
Imatinib—Rash—Furosemide—coronary artery disease	1.87e-05	0.000117	CcSEcCtD
Imatinib—Dermatitis—Furosemide—coronary artery disease	1.87e-05	0.000117	CcSEcCtD
Imatinib—Nausea—Captopril—coronary artery disease	1.87e-05	0.000117	CcSEcCtD
Imatinib—Headache—Furosemide—coronary artery disease	1.86e-05	0.000117	CcSEcCtD
Imatinib—Feeling abnormal—Lisinopril—coronary artery disease	1.84e-05	0.000115	CcSEcCtD
Imatinib—Gastrointestinal pain—Lisinopril—coronary artery disease	1.82e-05	0.000114	CcSEcCtD
Imatinib—Vomiting—Losartan—coronary artery disease	1.82e-05	0.000114	CcSEcCtD
Imatinib—Nausea—Perindopril—coronary artery disease	1.82e-05	0.000114	CcSEcCtD
Imatinib—Hypersensitivity—Ramipril—coronary artery disease	1.81e-05	0.000113	CcSEcCtD
Imatinib—Rash—Losartan—coronary artery disease	1.81e-05	0.000113	CcSEcCtD
Imatinib—Dermatitis—Losartan—coronary artery disease	1.81e-05	0.000113	CcSEcCtD
Imatinib—Headache—Losartan—coronary artery disease	1.8e-05	0.000113	CcSEcCtD
Imatinib—Urticaria—Lisinopril—coronary artery disease	1.77e-05	0.000111	CcSEcCtD
Imatinib—Hypersensitivity—Timolol—coronary artery disease	1.77e-05	0.000111	CcSEcCtD
Imatinib—Nausea—Furosemide—coronary artery disease	1.77e-05	0.000111	CcSEcCtD
Imatinib—Asthenia—Ramipril—coronary artery disease	1.76e-05	0.000111	CcSEcCtD
Imatinib—Body temperature increased—Lisinopril—coronary artery disease	1.76e-05	0.00011	CcSEcCtD
Imatinib—Abdominal pain—Lisinopril—coronary artery disease	1.76e-05	0.00011	CcSEcCtD
Imatinib—Pruritus—Ramipril—coronary artery disease	1.74e-05	0.000109	CcSEcCtD
Imatinib—Asthenia—Timolol—coronary artery disease	1.72e-05	0.000108	CcSEcCtD
Imatinib—Nausea—Losartan—coronary artery disease	1.7e-05	0.000107	CcSEcCtD
Imatinib—Pruritus—Timolol—coronary artery disease	1.7e-05	0.000107	CcSEcCtD
Imatinib—Diarrhoea—Ramipril—coronary artery disease	1.68e-05	0.000105	CcSEcCtD
Imatinib—Diarrhoea—Timolol—coronary artery disease	1.64e-05	0.000103	CcSEcCtD
Imatinib—Hypersensitivity—Lisinopril—coronary artery disease	1.64e-05	0.000103	CcSEcCtD
Imatinib—Dizziness—Ramipril—coronary artery disease	1.63e-05	0.000102	CcSEcCtD
Imatinib—Asthenia—Lisinopril—coronary artery disease	1.6e-05	0.0001	CcSEcCtD
Imatinib—Dizziness—Timolol—coronary artery disease	1.59e-05	9.96e-05	CcSEcCtD
Imatinib—Pruritus—Lisinopril—coronary artery disease	1.58e-05	9.88e-05	CcSEcCtD
Imatinib—Vomiting—Ramipril—coronary artery disease	1.56e-05	9.79e-05	CcSEcCtD
Imatinib—Rash—Ramipril—coronary artery disease	1.55e-05	9.71e-05	CcSEcCtD
Imatinib—Dermatitis—Ramipril—coronary artery disease	1.55e-05	9.7e-05	CcSEcCtD
Imatinib—Headache—Ramipril—coronary artery disease	1.54e-05	9.65e-05	CcSEcCtD
Imatinib—Vomiting—Timolol—coronary artery disease	1.53e-05	9.57e-05	CcSEcCtD
Imatinib—Diarrhoea—Lisinopril—coronary artery disease	1.53e-05	9.56e-05	CcSEcCtD
Imatinib—Rash—Timolol—coronary artery disease	1.52e-05	9.49e-05	CcSEcCtD
Imatinib—Dermatitis—Timolol—coronary artery disease	1.51e-05	9.49e-05	CcSEcCtD
Imatinib—Headache—Timolol—coronary artery disease	1.51e-05	9.43e-05	CcSEcCtD
Imatinib—Dizziness—Lisinopril—coronary artery disease	1.47e-05	9.24e-05	CcSEcCtD
Imatinib—Nausea—Ramipril—coronary artery disease	1.46e-05	9.15e-05	CcSEcCtD
Imatinib—Nausea—Timolol—coronary artery disease	1.43e-05	8.94e-05	CcSEcCtD
Imatinib—Vomiting—Lisinopril—coronary artery disease	1.42e-05	8.88e-05	CcSEcCtD
Imatinib—Rash—Lisinopril—coronary artery disease	1.41e-05	8.81e-05	CcSEcCtD
Imatinib—Dermatitis—Lisinopril—coronary artery disease	1.4e-05	8.8e-05	CcSEcCtD
Imatinib—Headache—Lisinopril—coronary artery disease	1.4e-05	8.75e-05	CcSEcCtD
Imatinib—Nausea—Lisinopril—coronary artery disease	1.32e-05	8.3e-05	CcSEcCtD
Imatinib—PDGFRB—Immune System—PIK3CA—coronary artery disease	7.75e-07	6.89e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—CD36—coronary artery disease	7.73e-07	6.87e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CAT—coronary artery disease	7.69e-07	6.84e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—APOB—coronary artery disease	7.65e-07	6.8e-06	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—NOS3—coronary artery disease	7.64e-07	6.79e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—PPP2CA—coronary artery disease	7.64e-07	6.79e-06	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL6—coronary artery disease	7.62e-07	6.77e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—DCN—coronary artery disease	7.6e-07	6.75e-06	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PTGS2—coronary artery disease	7.58e-07	6.73e-06	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CASP3—coronary artery disease	7.56e-07	6.72e-06	CbGpPWpGaD
Imatinib—ABL1—Immune System—PIK3CA—coronary artery disease	7.56e-07	6.72e-06	CbGpPWpGaD
Imatinib—CA9—Metabolism—AKT1—coronary artery disease	7.53e-07	6.7e-06	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—VEGFA—coronary artery disease	7.53e-07	6.69e-06	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PTGS2—coronary artery disease	7.51e-07	6.67e-06	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PTGS2—coronary artery disease	7.5e-07	6.66e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—SERPINE1—coronary artery disease	7.49e-07	6.66e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PLCB1—coronary artery disease	7.49e-07	6.65e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—APOB—coronary artery disease	7.47e-07	6.64e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GSTP1—coronary artery disease	7.45e-07	6.62e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GSTM1—coronary artery disease	7.44e-07	6.62e-06	CbGpPWpGaD
Imatinib—KIT—Disease—IL6—coronary artery disease	7.43e-07	6.61e-06	CbGpPWpGaD
Imatinib—KIT—Immune System—AKT1—coronary artery disease	7.43e-07	6.6e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ALDH2—coronary artery disease	7.39e-07	6.57e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GSTP1—coronary artery disease	7.39e-07	6.56e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	7.38e-07	6.56e-06	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CCND1—coronary artery disease	7.36e-07	6.54e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—HMOX1—coronary artery disease	7.35e-07	6.53e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	7.34e-07	6.52e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—MTHFR—coronary artery disease	7.33e-07	6.51e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	7.32e-07	6.5e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—LPL—coronary artery disease	7.31e-07	6.49e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—HMOX1—coronary artery disease	7.29e-07	6.47e-06	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PTGS2—coronary artery disease	7.28e-07	6.47e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GSTM1—coronary artery disease	7.27e-07	6.46e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ABCA1—coronary artery disease	7.26e-07	6.45e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CAT—coronary artery disease	7.25e-07	6.44e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—FGF2—coronary artery disease	7.25e-07	6.44e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—LIPC—coronary artery disease	7.2e-07	6.4e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CYP2C19—coronary artery disease	7.2e-07	6.4e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—HBA1—coronary artery disease	7.2e-07	6.4e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	7.2e-07	6.4e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CAT—coronary artery disease	7.19e-07	6.39e-06	CbGpPWpGaD
Imatinib—LCK—Immune System—MAPK1—coronary artery disease	7.17e-07	6.37e-06	CbGpPWpGaD
Imatinib—PDGFRB—Disease—PIK3CA—coronary artery disease	7.16e-07	6.36e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—APOC3—coronary artery disease	7.16e-07	6.36e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NOS3—coronary artery disease	7.15e-07	6.35e-06	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—MMP9—coronary artery disease	7.15e-07	6.35e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—LPL—coronary artery disease	7.13e-07	6.34e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GPX1—coronary artery disease	7.13e-07	6.33e-06	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—VEGFA—coronary artery disease	7.13e-07	6.33e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—LDLR—coronary artery disease	7.11e-07	6.32e-06	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—IL6—coronary artery disease	7.11e-07	6.31e-06	CbGpPWpGaD
Imatinib—ALB—Hemostasis—PIK3CA—coronary artery disease	7.09e-07	6.3e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—APOB—coronary artery disease	7.04e-07	6.25e-06	CbGpPWpGaD
Imatinib—PDGFRA—Disease—IL6—coronary artery disease	7.04e-07	6.25e-06	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—AKT1—coronary artery disease	7.03e-07	6.25e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GSTT1—coronary artery disease	7.03e-07	6.25e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SLC9A1—coronary artery disease	7.03e-07	6.25e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GOT1—coronary artery disease	7.03e-07	6.24e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GGT1—coronary artery disease	7.03e-07	6.24e-06	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PTGS2—coronary artery disease	6.99e-07	6.21e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—APOB—coronary artery disease	6.98e-07	6.2e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—AGT—coronary artery disease	6.96e-07	6.19e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GPX1—coronary artery disease	6.96e-07	6.18e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—JAK2—coronary artery disease	6.95e-07	6.18e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CETP—coronary artery disease	6.95e-07	6.17e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GCLC—coronary artery disease	6.95e-07	6.17e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CD36—coronary artery disease	6.94e-07	6.17e-06	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TGFB1—coronary artery disease	6.91e-07	6.14e-06	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PPARG—coronary artery disease	6.9e-07	6.13e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SDC1—coronary artery disease	6.87e-07	6.1e-06	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL6—coronary artery disease	6.87e-07	6.1e-06	CbGpPWpGaD
Imatinib—KIT—Disease—AKT1—coronary artery disease	6.86e-07	6.09e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PPP2CA—coronary artery disease	6.86e-07	6.09e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GSTM1—coronary artery disease	6.85e-07	6.08e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—APOE—coronary artery disease	6.82e-07	6.06e-06	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—POMC—coronary artery disease	6.81e-07	6.05e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GSTM1—coronary artery disease	6.79e-07	6.03e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CD36—coronary artery disease	6.78e-07	6.02e-06	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—MAPK1—coronary artery disease	6.78e-07	6.02e-06	CbGpPWpGaD
Imatinib—LCK—Disease—TGFB1—coronary artery disease	6.75e-07	6e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—APOA1—coronary artery disease	6.75e-07	5.99e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—LPL—coronary artery disease	6.72e-07	5.97e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PPP2CA—coronary artery disease	6.69e-07	5.95e-06	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL6—coronary artery disease	6.69e-07	5.95e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—LPL—coronary artery disease	6.66e-07	5.92e-06	CbGpPWpGaD
Imatinib—LCK—Disease—MAPK1—coronary artery disease	6.62e-07	5.88e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—MTHFR—coronary artery disease	6.58e-07	5.85e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GPX1—coronary artery disease	6.56e-07	5.83e-06	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—AKT1—coronary artery disease	6.55e-07	5.82e-06	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TGFB1—coronary artery disease	6.54e-07	5.81e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GPX1—coronary artery disease	6.5e-07	5.78e-06	CbGpPWpGaD
Imatinib—PDGFRA—Disease—AKT1—coronary artery disease	6.49e-07	5.77e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PSMB5—coronary artery disease	6.49e-07	5.77e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PSMA6—coronary artery disease	6.49e-07	5.77e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	6.46e-07	5.74e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—MTHFR—coronary artery disease	6.42e-07	5.71e-06	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—VEGFA—coronary artery disease	6.42e-07	5.7e-06	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—MAPK1—coronary artery disease	6.41e-07	5.7e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CD36—coronary artery disease	6.39e-07	5.67e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CXCL8—coronary artery disease	6.34e-07	5.64e-06	CbGpPWpGaD
Imatinib—PDGFRB—Disease—IL6—coronary artery disease	6.34e-07	5.63e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CTGF—coronary artery disease	6.34e-07	5.63e-06	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—AKT1—coronary artery disease	6.34e-07	5.63e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CD36—coronary artery disease	6.33e-07	5.63e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GSTP1—coronary artery disease	6.31e-07	5.61e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PPP2CA—coronary artery disease	6.31e-07	5.6e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GOT2—coronary artery disease	6.28e-07	5.58e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—HMGCR—coronary artery disease	6.28e-07	5.58e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	6.25e-07	5.56e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PPP2CA—coronary artery disease	6.25e-07	5.55e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—AGT—coronary artery disease	6.25e-07	5.55e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—HMOX1—coronary artery disease	6.23e-07	5.53e-06	CbGpPWpGaD
Imatinib—LCK—Immune System—PIK3CA—coronary artery disease	6.22e-07	5.53e-06	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ALB—coronary artery disease	6.21e-07	5.51e-06	CbGpPWpGaD
Imatinib—ABL1—Immune System—AKT1—coronary artery disease	6.17e-07	5.49e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CAT—coronary artery disease	6.14e-07	5.46e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—APOE—coronary artery disease	6.13e-07	5.44e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—AGT—coronary artery disease	6.1e-07	5.42e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CASP3—coronary artery disease	6.07e-07	5.39e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—APOA1—coronary artery disease	6.06e-07	5.38e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—MTHFR—coronary artery disease	6.05e-07	5.38e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—MTHFR—coronary artery disease	6e-07	5.33e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—APOE—coronary artery disease	5.98e-07	5.31e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—APOB—coronary artery disease	5.96e-07	5.3e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—PPARG—coronary artery disease	5.94e-07	5.28e-06	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—NOS3—coronary artery disease	5.94e-07	5.27e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—APOA1—coronary artery disease	5.91e-07	5.25e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CCND1—coronary artery disease	5.91e-07	5.25e-06	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TGFB1—coronary artery disease	5.89e-07	5.24e-06	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—PIK3CA—coronary artery disease	5.88e-07	5.22e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—POMC—coronary artery disease	5.86e-07	5.21e-06	CbGpPWpGaD
Imatinib—PDGFRB—Disease—AKT1—coronary artery disease	5.85e-07	5.2e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GSTM1—coronary artery disease	5.8e-07	5.15e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5.8e-07	5.15e-06	CbGpPWpGaD
Imatinib—ALB—Hemostasis—AKT1—coronary artery disease	5.8e-07	5.15e-06	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—MAPK1—coronary artery disease	5.78e-07	5.13e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PLCB1—coronary artery disease	5.78e-07	5.13e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—AGT—coronary artery disease	5.75e-07	5.11e-06	CbGpPWpGaD
Imatinib—LCK—Disease—PIK3CA—coronary artery disease	5.75e-07	5.11e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MMP9—coronary artery disease	5.74e-07	5.1e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—AGT—coronary artery disease	5.7e-07	5.06e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—LPL—coronary artery disease	5.69e-07	5.06e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—APOE—coronary artery disease	5.63e-07	5.01e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ABCA1—coronary artery disease	5.6e-07	4.98e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—APOE—coronary artery disease	5.59e-07	4.96e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—APOA1—coronary artery disease	5.57e-07	4.95e-06	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—PIK3CA—coronary artery disease	5.57e-07	4.95e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GPX1—coronary artery disease	5.55e-07	4.94e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—APOA1—coronary artery disease	5.52e-07	4.91e-06	CbGpPWpGaD
Imatinib—LCK—Immune System—IL6—coronary artery disease	5.51e-07	4.9e-06	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PTGS2—coronary artery disease	5.43e-07	4.82e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GGT1—coronary artery disease	5.42e-07	4.82e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GOT1—coronary artery disease	5.42e-07	4.82e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CD36—coronary artery disease	5.41e-07	4.81e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PPP2CA—coronary artery disease	5.34e-07	4.75e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PPARG—coronary artery disease	5.34e-07	4.74e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5.29e-07	4.7e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—POMC—coronary artery disease	5.26e-07	4.68e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PPARG—coronary artery disease	5.21e-07	4.63e-06	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL6—coronary artery disease	5.21e-07	4.63e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—VEGFA—coronary artery disease	5.15e-07	4.58e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—POMC—coronary artery disease	5.14e-07	4.56e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—MTHFR—coronary artery disease	5.13e-07	4.56e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—NOS3—coronary artery disease	5.11e-07	4.54e-06	CbGpPWpGaD
Imatinib—LCK—Disease—IL6—coronary artery disease	5.09e-07	4.52e-06	CbGpPWpGaD
Imatinib—LCK—Immune System—AKT1—coronary artery disease	5.08e-07	4.52e-06	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—PIK3CA—coronary artery disease	5.01e-07	4.46e-06	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL6—coronary artery disease	4.93e-07	4.38e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PPARG—coronary artery disease	4.91e-07	4.36e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GSTP1—coronary artery disease	4.87e-07	4.33e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—AGT—coronary artery disease	4.87e-07	4.33e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PPARG—coronary artery disease	4.86e-07	4.32e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—POMC—coronary artery disease	4.84e-07	4.3e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	4.83e-07	4.29e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—HMOX1—coronary artery disease	4.8e-07	4.27e-06	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—AKT1—coronary artery disease	4.8e-07	4.27e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—POMC—coronary artery disease	4.8e-07	4.26e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ALB—coronary artery disease	4.8e-07	4.26e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—APOE—coronary artery disease	4.77e-07	4.24e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CAT—coronary artery disease	4.74e-07	4.21e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TGFB1—coronary artery disease	4.73e-07	4.2e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—APOA1—coronary artery disease	4.72e-07	4.19e-06	CbGpPWpGaD
Imatinib—LCK—Disease—AKT1—coronary artery disease	4.69e-07	4.17e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ALB—coronary artery disease	4.68e-07	4.16e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—PTGS2—coronary artery disease	4.68e-07	4.15e-06	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PIK3CA—coronary artery disease	4.66e-07	4.14e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MAPK1—coronary artery disease	4.64e-07	4.12e-06	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PIK3CA—coronary artery disease	4.62e-07	4.11e-06	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PIK3CA—coronary artery disease	4.61e-07	4.1e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—APOB—coronary artery disease	4.6e-07	4.09e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—NOS3—coronary artery disease	4.59e-07	4.08e-06	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—AKT1—coronary artery disease	4.55e-07	4.04e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.52e-07	4.01e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—NOS3—coronary artery disease	4.48e-07	3.98e-06	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PIK3CA—coronary artery disease	4.48e-07	3.98e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GSTM1—coronary artery disease	4.48e-07	3.98e-06	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL6—coronary artery disease	4.44e-07	3.95e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ALB—coronary artery disease	4.41e-07	3.92e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—LPL—coronary artery disease	4.39e-07	3.9e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ALB—coronary artery disease	4.37e-07	3.89e-06	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PIK3CA—coronary artery disease	4.3e-07	3.82e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GPX1—coronary artery disease	4.29e-07	3.81e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—NOS3—coronary artery disease	4.22e-07	3.75e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PTGS2—coronary artery disease	4.2e-07	3.73e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—NOS3—coronary artery disease	4.18e-07	3.72e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CD36—coronary artery disease	4.18e-07	3.71e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PPARG—coronary artery disease	4.16e-07	3.69e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PPP2CA—coronary artery disease	4.12e-07	3.66e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—POMC—coronary artery disease	4.1e-07	3.64e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PTGS2—coronary artery disease	4.1e-07	3.64e-06	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—AKT1—coronary artery disease	4.1e-07	3.64e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—PIK3CA—coronary artery disease	4.02e-07	3.58e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MTHFR—coronary artery disease	3.96e-07	3.52e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PTGS2—coronary artery disease	3.86e-07	3.43e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PTGS2—coronary artery disease	3.83e-07	3.4e-06	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—AKT1—coronary artery disease	3.81e-07	3.38e-06	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—AKT1—coronary artery disease	3.77e-07	3.35e-06	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—AKT1—coronary artery disease	3.77e-07	3.35e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—AGT—coronary artery disease	3.76e-07	3.34e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ALB—coronary artery disease	3.74e-07	3.32e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—APOE—coronary artery disease	3.68e-07	3.27e-06	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—AKT1—coronary artery disease	3.66e-07	3.25e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—APOA1—coronary artery disease	3.64e-07	3.24e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—NOS3—coronary artery disease	3.58e-07	3.18e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL6—coronary artery disease	3.56e-07	3.17e-06	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—AKT1—coronary artery disease	3.51e-07	3.12e-06	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PIK3CA—coronary artery disease	3.34e-07	2.97e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—AKT1—coronary artery disease	3.29e-07	2.92e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PTGS2—coronary artery disease	3.27e-07	2.91e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PPARG—coronary artery disease	3.21e-07	2.85e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—POMC—coronary artery disease	3.16e-07	2.81e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ALB—coronary artery disease	2.88e-07	2.56e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—PIK3CA—coronary artery disease	2.88e-07	2.56e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—NOS3—coronary artery disease	2.76e-07	2.45e-06	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—AKT1—coronary artery disease	2.73e-07	2.42e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PIK3CA—coronary artery disease	2.58e-07	2.29e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PTGS2—coronary artery disease	2.52e-07	2.24e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PIK3CA—coronary artery disease	2.52e-07	2.24e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PIK3CA—coronary artery disease	2.37e-07	2.11e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PIK3CA—coronary artery disease	2.35e-07	2.09e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—AKT1—coronary artery disease	2.35e-07	2.09e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—AKT1—coronary artery disease	2.11e-07	1.87e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—AKT1—coronary artery disease	2.06e-07	1.83e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PIK3CA—coronary artery disease	2.01e-07	1.79e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—AKT1—coronary artery disease	1.94e-07	1.72e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—AKT1—coronary artery disease	1.92e-07	1.71e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—AKT1—coronary artery disease	1.64e-07	1.46e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.55e-07	1.38e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—AKT1—coronary artery disease	1.27e-07	1.13e-06	CbGpPWpGaD
